General side effects: tiredness, headache, muscle pain, chills, joint pain, fever, nausea, feeling unwell, swollen lymph ...

The U.S. continues to charge significantly higher prices for prescription drugs compared with similarly wealthy countries.

The sale decreases Pfizer’s shareholding in the consumer-healthcare business to 7.3% of its issued share capital, down from ...

Pfizer CEO highlights savings, leadership changes, and acquisition-driven growth amid significant revenue loss challenges ...

Reeling off a list of several programmes ... drugs will continue to deliver for Pfizer however, and elsewhere the results were not so impressive. Oncology products fell 2% to $3.1 billion, dragged ...

Bernstein analyst Courtney Breen maintained a Hold rating on Pfizer (PFE – Research Report) today and set a price target of $32.00. The ...

The start of the new year is typically a time when people make big changes around health—and drug companies are no exception. Pfizer alone is raising prices on over 60 drugs, the most on the list.